UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Esterification using a liquid lipase to remove residual free fatty acids in biodiesel

Process biochemistry (1991), 2020-10, Vol.97, p.213-221

2020

Volltextzugriff (PDF)

Renal impairment and late toxicity in germ-cell cancer survivors

Annals of oncology, 2015-01, Vol.26 (1), p.173-178

2015

Volltextzugriff (PDF)

Résultats actualisés de l’essai de phase 3 checkmate 274 évaluant nivolumab adjuvant (NIVO) versus placebo (PBO) chez les patients atteints de carcinome urothélial infiltrant le muscle (CUIM) à haut risque après résection complète

Progrès en urologie. Formation médicale continue, 2023-11, Vol.33 (3), p.S67

2023

Volltextzugriff (PDF)

Sexual function and quality of life in a national cohort of bilateral testicular cancer survivors

Annals of oncology, 2018-10, Vol.29, p.viii324-viii324

2018

Volltextzugriff (PDF)

Résultats actualisés de survie sans maladie (DFS) de l’essai de phase 3 CheckMate 274, évaluant le nivolumab en adjuvant chez les patients atteints d’un carcinome urothélial infiltrant le muscle à haut risque de récidive (CUIM-HR) après exérèse complète

Progrès en urologie. Formation médicale continue, 2022-11, Vol.32 (3), p.S97-S98

2022

Volltextzugriff (PDF)

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer

British journal of cancer, 2011-10, Vol.105 (9), p.1379-1387

2011

Volltextzugriff (PDF)

Combination of Zoledronic Acid and Targeted Therapy Is Active But May Induce Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Carcinoma

Journal of oral and maxillofacial surgery, 2013-09, Vol.71 (9), p.1532-1540

2013

Volltextzugriff (PDF)

2506 Risk of death and second primary cancer (SPC) in patients treated for germ cell cancer (GCC)

European journal of cancer (1990), 2015-09, Vol.51, p.S475-S475

2015

Volltextzugriff (PDF)

Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy – results of an exploratory phase I study

Investigational new drugs, 2018-08, Vol.36 (4), p.615-618

2018

Volltextzugriff (PDF)

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

The New England journal of medicine, 2021-06, Vol.384 (22), p.2102-2114

2021

Volltextzugriff (PDF)

Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men

European journal of clinical nutrition, 1995-05, Vol.49 (5), p.346-352

1995

Volltextzugriff (PDF)

Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)

European journal of cancer (1990), 2020-03, Vol.127, p.173-182

2020

Volltextzugriff (PDF)

912PSexual function and quality of life in a national cohort of bilateral testicular cancer survivors

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Conditioning, Filtering, and Expressing Waste Activated Sludge

Journal of environmental engineering (New York, N.Y.), 1999-09, Vol.125 (9), p.816-824

1999

Volltextzugriff (PDF)

Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer

British journal of cancer, 2003-07, Vol.89 (2), p.298-304

2003

Volltextzugriff (PDF)

Prediction of complete local response after neoadjuvant chemotherapy in muscle invasive bladder cancer by 15O-H2O PET/MRI

European urology open science (Online), 2021-11, Vol.33, p.S179

2021

Volltextzugriff (PDF)

Quality of life (QoL) and neurotoxicity in germ-cell cancer survivors (GCCS)

Annals of oncology, 2016-10, Vol.27, p.vi268-vi268

2016

Volltextzugriff (PDF)

Distribution of early atherosclerotic lesions in the human abdominal aorta correlates with wall shear stresses measured in vivo

European journal of vascular and endovascular surgery, 1999-10, Vol.18 (4), p.328-333

1999

Volltextzugriff (PDF)

Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen

Bladder cancer, 2022-01, Vol.8 (1), p.71-80

2022

Volltextzugriff (PDF)

Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase 3 CheckMate 274 trial

European urology open science (Online), 2022-11, Vol.45, p.S239-S240

2022

Volltextzugriff (PDF)

Prognostic factors and survival in germ cell cancer (GCC) patients treated with bleomycin, etoposide, and cisplatin (BEP): A population-based study

Annals of oncology, 2016-10, Vol.27, p.vi291-vi291

2016

Volltextzugriff (PDF)

2599 Gemcitabine, Cisplatin, and Paclitaxel (GCT) as second-line salvage chemotherapy for germ cell tumors

European journal of cancer (1990), 2015-09, Vol.51, p.S511-S511

2015

Volltextzugriff (PDF)

Longitudinal assessment of multiplex patient-specific ctDNA biomarkers in bladder cancer for diagnosis, surveillance and recurrence

Annals of oncology, 2018-10, Vol.29, p.viii26-viii27

2018

Volltextzugriff (PDF)

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

The lancet oncology, 2015-01, Vol.16 (1), p.76-86

2015

Volltextzugriff (PDF)

Wall shear stress and early atherosclerotic lesions in the abdominal aorta in young adults

European journal of vascular and endovascular surgery, 1997-05, Vol.13 (5), p.443-451

1997

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(86)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Esterification using a liquid lipase to remove residual free fatty acids in biodiesel

Renal impairment and late toxicity in germ-cell cancer survivors

Résultats actualisés de l’essai de phase 3 checkmate 274 évaluant nivolumab adjuvant (NIVO) versus placebo (PBO) chez les patients atteints de carcinome urothélial infiltrant le muscle (CUIM) à haut risque après résection complète

Sexual function and quality of life in a national cohort of bilateral testicular cancer survivors

Résultats actualisés de survie sans maladie (DFS) de l’essai de phase 3 CheckMate 274, évaluant le nivolumab en adjuvant chez les patients atteints d’un carcinome urothélial infiltrant le muscle à haut risque de récidive (CUIM-HR) après exérèse complète

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer

Combination of Zoledronic Acid and Targeted Therapy Is Active But May Induce Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Carcinoma

2506 Risk of death and second primary cancer (SPC) in patients treated for germ cell cancer (GCC)

Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy – results of an exploratory phase I study

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men

Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)

912PSexual function and quality of life in a national cohort of bilateral testicular cancer survivors

Conditioning, Filtering, and Expressing Waste Activated Sludge

Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer

Prediction of complete local response after neoadjuvant chemotherapy in muscle invasive bladder cancer by 15O-H2O PET/MRI

Quality of life (QoL) and neurotoxicity in germ-cell cancer survivors (GCCS)

Distribution of early atherosclerotic lesions in the human abdominal aorta correlates with wall shear stresses measured in vivo

Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen

Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase 3 CheckMate 274 trial

Prognostic factors and survival in germ cell cancer (GCC) patients treated with bleomycin, etoposide, and cisplatin (BEP): A population-based study

2599 Gemcitabine, Cisplatin, and Paclitaxel (GCT) as second-line salvage chemotherapy for germ cell tumors

Longitudinal assessment of multiplex patient-specific ctDNA biomarkers in bladder cancer for diagnosis, surveillance and recurrence

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Wall shear stress and early atherosclerotic lesions in the abdominal aorta in young adults

Suchergebnisse filtern